Immediate Breast Reconstruction Using Silicone Implants in Previously Augmented Patients

Article information

Arch Aesthetic Plast Surg. 2016;22(1):15-19
Publication date (electronic) : 2016 March 4
doi : https://doi.org/10.14730/aaps.2016.22.1.15
1Department of Plastic and Reconstructive Surgery, Kyungpook National University School of Medicine, Daegu, Korea
2Department of Surgery, Kyungpook National University School of Medicine, Daegu, Korea
Correspondence: Jung Dug Yang Department of Plastic and Reconstructive Surgery, Kyungpook National University School of Medicine, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Korea. E-mail: lambyang@daum.net
Received 2016 January 25; Revised 2016 February 19; Accepted 2016 February 20.

Abstract

Background

Augmentation mammoplasty is rapidly becoming one of the most frequently performed cosmetic surgeries. Consequently, the number of breast cancer patients with a history of breast augmentation surgery will increase. The purpose of this study is to report our experience of breast reconstruction in augmented women and discuss their treatment characteristics.

Methods

From March 2010 to August 2015, 7 patients who had previously undergone breast augmentation were treated at our institution. Epidemiologic data as well as data regarding body mass index, types of mastectomy, and complication were recorded and analyzed.

Results

The mean age was 43.4 years, the average follow-up period was 21 months, and the mean body mass index (BMI) was 19.3 kg/m2, the average weight of the mastectomy specimen was 150 g. Implant-based immediate breast reconstruction after skin-sparing mastectomy was performed in seven patients and in four of these patients, acellular dermal matrix (ADM) was used. One patient had a capsular contracture of Baker grade II. One patient had seroma.

Conclusions

Previously augmented patients tend to have a slender abdomen and back. Moreover, Asians have a smaller body frame and lower muscle and fat percentage than westerners, making it more suitable for implant-based reconstruction than autologous tissue. It can be recommended as a surgical method as our patients were highly satisfied with the cosmetic outcomes.

INTRODUCTION

Augmentation mammoplasty is one of the most frequently performed cosmetic surgeries worldwide. According to Cahan et al. [1], no statistical significance was noted in the mean tumor size, stage, nodal status of breast cancer between augmented patient group and non-augmented patients. Since the rate of breast cancer is radically increasing, and breast augmentation surgery is performed actively over the recent years, the need for combined performance of breast cancer surgery and reconstruction in previously augmented patients is thus increasing [2,3].

The anatomical and physical properties of the breast in patients with a history of mammoplasty differ from those in patients who have not undergone mammoplasty. Moreover, the patient’s high interest in aesthetic appearance and having significantly less breast tissue shows the difference from those patients who have not undergone mammoplasty.

Patients who have undergone breast augmentation commonly have a low body mass index (BMI), lesser lower abdominal and back tissue limits in harvesting autologous tissues [4]. Meanwhile, skin-sparing mastectomy enables immediate implant-based breast reconstruction. By utilizing the existing implants inserted space, new implants can be inserted more easily. We report our experience of treating breast cancer patients after breast augmentation with skin-sparing mastectomy and breast reconstruction with satisfactory results.

METHODS

An individual plastic surgeon performed breast augmentation to total of seven patients from March 2010 to August 2015. Patient’s Information regarding underlying disease, age, BMI, smoking history, irradiation history, weight and skin surface of the excised breast during surgery, postoperative complications, reoperation, usage of acellular dermal matrix (ADM), and sizes and kinds of replaced implants were obtained from the medical records. Information regarding postoperative chemotherapy and radiotherapy were additionally obtained. Six months after the surgery, we followed up with the level of cosmetic satisfaction including breast symmetry and overall cosmetic effectiveness with both patients and the surgeon.

As a surgical method, first skin-sparing or nipple sparing mastectomy was performed by an oncologic breast surgeon, and a plastic surgeon removed the already inserted implant in subpectoral or subglandular plane. Capsulectomy was performed if it was placed in subglandular plane and a new implant was inserted after a space to insert an implant was created by dissecting subpectoral area. ADM covered the implant using a sling for pectoralis muscle. When an implant was located in the subpectoral plane, the area of previous adhesion was dissected after the implant was removed. Then, capsulectomy was performed and thus an enough space for the insertion of a new implant was created. In one case, onlay graft of ADM was performed in order to prevent irregularity and dimpling, which develops as breast skin flap is thin. In order to prevent post-operative infection, sufficient irrigation was performed using the mixed solution of antibiotics and potadine. For a new implant, the approximate size was predicted by measuring the pre-operative breast volume and width of a patient. Then, the implant size was selected when it was most symmetric with the opposite side in a sitting position once a sizer was applied during surgery.

Referencing Kyungpook National University Hospital (KNUH) breast reconstruction satisfaction questionnaire (A total of 11 items), a survey was conducted among patients 6 months after the surgery regarding overall and cosmetic satisfaction (Table 1). Each item was graded on a 5-point scale from highly dissatisfied (1) to highly satisfied (5). Three plastic surgeons evaluated the postoperative photographs (6 months) from very bad (1) to very good (5) in accordance with Likert scale.

KNUH breast reconstruction satisfaction questionnaire

RESULTS

A total of seven patients with a mean age of 43.4 years (range, 31-54 years) were investigated from March 2010 to August 2015. The mean follow up period by the outpatient clinic was 21 months (range, 6-31 months). The mean BMI was 19.3 kg/m2 (range, 17.5-21.9) and the mean excised mass weight was 150 g (range, 68-260 g). Four of the patients existing breast implant location was at the subpectoral plane, and the rest three patients were at the subglandular plane. Implants were replaced after mastectomy. A total of four patients had implants covered by ADM; where three of these patients had implants placed in subpectoral and subgraft pocket with ADM acting as a sling (Fig. 1). One patient underwent onlay graft to prevent depression and irregularity due to a thin breast skin flap after skin-sparing mastectomy (Fig. 2). In terms of tumor diagnosis, one patient had lobular carcinoma in situ, three had invasive ductal carcinoma, and three had ductal carcinoma in situ. Baker grade II capsular contracture was developed in 1 case, and 1 case of seroma was noted after surgery. Characteristics of patients are shown in Table 2. The mean patient satisfaction score was 4.27 point, and the mean satisfaction score rated by plastic surgeons was 4.21 points.

Fig. 1.

A 54-year-old woman with lobular carcinoma in situ (LCIS) in left upper outer breast. (A) Preoperative view. (B) Tissue after skin sparing mastectomy. (C) Intraoperative view of changed implant with acellular dermal matrix (ADM; sling) in the pocket after skin sparing mastectomy. (D) 10 months postoperative outcome.

Fig. 2.

A 39-year-old woman with ductal carcinoma in situ (DCIS) in left upper outer breast. (A) Preoperative view. (B) Tissue after skin sparing mastectomy. (C) In ora-operative view of changed implant with acellular dermal matrix (ADM; onlay graft) in the pocket after skin sparing mastectomy. (D) 18 months postoperative outcome.

Characteristics of the 7 patients who were reconstructed

DISCUSSION

Augmentation mammoplasty is currently one of the most commonly performed cosmetic surgeries [5]. There has been a 5-fold increase in the number of breast augmentation surgeries in the US, similarly, there has been a consistent increase in the number of breast augmentation surgeries in South Korea [2,3]. Irrespectively, the number of breast cancer cases is increasing; in South Korea, there were 16,967 patients with breast cancer in 2011, which was a 4-fold increase compared to the number of patients in 1996. This indicates that the possibility of developing breast cancer is increasing in patients who have undergone breast augmentation [6].

In patients who had undergone breast augmentation, the tumor was smaller, was more palpable, and had a lower clinical stage than that in patients who had not undergone breast augmentation. Moreover, previously augmented patients were younger at the time of diagnosis. It is known that implants do not influence estrogen receptor expression and lymph node metastasis. Furthermore, the survival rate and the local recurrence rate did not differ significantly between patients who have and have not undergone augmentation [7].

Generally, two surgical treatments are available for removing the tumor in previously augmented patients: breast-conserving surgery and mastectomy [4]. According to Singh et al. [8], patients who have undergone augmentation mammoplasty are not ideal candidates for breast-conserving surgery owing to its small breast size, and may experience distortion after lumpectomy. Handel et al. [9] reported that augmented breast cancer patients treated with breast conserving surgery have less cosmetic satisfaction. Moreover, mammographic follow-up for detection of the tumor recurrence may be impaired by the implants. The possibility of capsular formation may also increase after postoperative radiotherapy. Therefore, reconstruction by implants has cosmetic and oncologic limitations when breast conserving surgery is performed.

When performing mastectomy in patients with previously augmented breasts, the implant itself does not hinder the surgery as implants, scar, or capsules can be excised. If skin-sparing mastectomy is performed, it is possible to conduct one-stage breast reconstruction by replacing the existing one with new implants after mastectomy. If skin-sparing breast reconstruction is performed, it is possible to maintain the inframammary fold, normal skin color, texture, and sensation, and to decrease the size of scar [10]. Therefore, breast reconstruction using implants in patients with skin-sparing mastectomy is considered a better option that breast-conserving surgery.

An augmented breast normally requires more volume to maintain symmetry, as the controlateral breast is more enlarged than one’s own breast. However, patients who have undergone augmentation mammoplasty usually have low BMI and have slender abdomen and back. Especially for Asians tend to have smaller body frame with lower muscle and fat percentage compared to westerners, the usage of autologous tissue is restricted. The average BMI of the 7 patients we operated was 19.3 kg/m2, which limited the use of autologous tissue for defects that had occurred after skin-sparing mastectomy. Therefore, with the excised amount of breast tissue considered, we replaced it with a bigger implant to minimize volume difference from a controlateral breast [11].

According to Robbins et al. [12], indications for implant removal during mastectomy are as follows: implants in the subglandular position, rupture, infection, extrusion or expose of implants, capsular contracture, pain, seroma, outdated implants, cosmetic dissatisfaction, implants located in proximity to a tumor, and cases requiring irradiation. In all 7 patients of this study, a new implant was placed after previous implant was removed; In 3 patients, the implants were replaced, its location was altered from the subglandular to the subpectoral position, and the implants were covered by slinging ADM. In the rest of 4 patients, previous implants were removed due to cosmetic dissatisfaction and then new implants were inserted to make symmetry.

Roostaeian et al. [13] reported cases of complications that numbered 18 of 38 (63 breasts) with a history of augmentation and 20 of 77 (138 breasts) patients who had not undergone breast augmentation. Capsular contracture occurred most commonly, followed by wound dehiscence, hematoma, and infection. In our case, two among seven patients developed post-operative complications; One patient had Baker grade II capsular contracture and another had seroma.

Using the Breast Q, Salgarello et al. [11] investigated the level of satisfaction with reconstruction using implants in patients who had and had not undergone breast augmentation and found that those who had undergone breast augmentation previously showed higher satisfaction levels. Spear et al. [14] reported similar results. In this study, the patient group was small and thus it was not statistically significant. Also, there is a limitation that there is no appropriate control group, but the mean score of satisfaction was measured as relatively high. Using a breast reconstruction satisfaction questionnaire in our study, we reported a mean satisfaction score of 4.27 among patients and 4.21 among plastic surgeons, which are relatively high values. Patients who have undergone augmentation mammoplasty are concerned about cosmetic outcomes such as the breast size and shape, and they remained very satisfied after surgery because the breast shape was maintained.

This study, despite the small number of patients enrolled, achieved satisfying results in breast reconstruction using implants for breast cancer patients who had undergone breast augmentation previously, our findings are especially applicable in Asians and further studies are required to determine other populations where our findings may be applicable.

CONCLUSIONS

Since augmentation mammoplasty is performed actively worldwide, the need for surgery of breast cancer and reconstruction is also increasing from the patients with a history of breast augmentation. We reported seven cases showing that immediate implant-based reconstruction is suitable for previously augmented patients when skin-sparing mastectomy is performed. It is a good surgical option as our patients were highly satisfied with the cosmetic results.

Notes

No potential conflict of interest relevant to this article was reported.

PATIENT CONSENT

Patients provided written consent for the use of their images.

References

1. Cahan AC, Ashikari R, Pressman P, et al. Breast cancer after breast augmentation with silicone implants. Ann Surg Oncol 1995;2:121–5.
2. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29.
3. Korean Breast Cancer Society. Breast cancer facts & figures 2014. Seoul: Korean Breast Cancer Society; 2014.
4. McCarthy CM, Pusic AL, Disa JJ, et al. Breast cancer in the previously augmented breast. Plast Reconstr Surg 2007;119:49–58.
5. American Society of Plastic Surgeons. 2014 cosmetic plastic surgery statistics. 2015. [cited 2016 Feb 14]. Available from http://www.plasticsurgery.org/Documents/news-resources/statistics/2014-statistics/cosmetic-procedure-trends-2014.pdf.
6. Tuli R, Flynn RA, Brill KL, et al. Diagnosis, treatment, and management of breast cancer in previously augmented women. Breast J 2006;12:343–8.
7. Hölmich LR, Mellemkjaer L, Gunnarsdóttir KA, et al. Stage of breast cancer at diagnosis among women with cosmetic breast implants. Br J Cancer 2003;88:832–8.
8. Singh KA, Saunders N, Carlson GW. Immediate breast reconstruction in the previously augmented patient. Ann Plast Surg 2012;68:477–80.
9. Handel N, Lewinsky B, Jensen JA, et al. Breast conservation therapy after augmentation mammaplasty: is it appropriate? Plast Reconstr Surg 1996;98:1216–24.
10. Toth BA, Lappert P. Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning. Plast Reconstr Surg 1991;87:1048–53.
11. Salgarello M, Rochira D, Barone-Adesi L, et al. Immediate breast reconstruction after skin- or nipple-sparing mastectomy for previously augmented patients: a personal technique. Aesthetic Plast Surg 2012;36:313–22.
12. Robbins CM, Long JN, Fix RJ, et al. Mastectomy with breast reconstruction in previously augmented patients: indications for implant removal. Ann Plast Surg 2008;61:500–5.
13. Roostaeian J, Yoon AP, Rahgozar P, et al. Implant-based immediate breast reconstruction in the previously augmented patient. J Plast Reconstr Aesthet Surg 2015;68:e71–9.
14. Spear SL, Slack C, Howard MA. Postmastectomy reconstruction of the previously augmented breast: diagnosis, staging, methodology, and outcome. Plast Reconstr Surg 2001;107:1167–76.

Article information Continued

Fig. 1.

A 54-year-old woman with lobular carcinoma in situ (LCIS) in left upper outer breast. (A) Preoperative view. (B) Tissue after skin sparing mastectomy. (C) Intraoperative view of changed implant with acellular dermal matrix (ADM; sling) in the pocket after skin sparing mastectomy. (D) 10 months postoperative outcome.

Fig. 2.

A 39-year-old woman with ductal carcinoma in situ (DCIS) in left upper outer breast. (A) Preoperative view. (B) Tissue after skin sparing mastectomy. (C) In ora-operative view of changed implant with acellular dermal matrix (ADM; onlay graft) in the pocket after skin sparing mastectomy. (D) 18 months postoperative outcome.

Table 1.

KNUH breast reconstruction satisfaction questionnaire

Question Very dissatisfied → Very satisfied Mean score
Q1. Overall satisfaction with my breast reconstruction 1  2  3  4  5 4.31
Q2. Symmetry of my breasts 1  2  3  4  5 4.24
Q3. Size of my reconstructed breast 1  2  3  4  5 4.41
Q4. Shape of my reconstructed breast 1  2  3  4  5 4.37
Q5. Feel to touch my reconstructed breast 1  2  3  4  5 3.93
Q6. Pain in my reconstructed breast 1  2  3  4  5 4.18
Q7. Scar of my reconstructed breast 1  2  3  4  5 4.41
Q8. Donor site pain N/A -
Q9. Donor site scar N/A -
Q10. Self-confidence 1  2  3  4  5 4.28
Q11. Sexual attractiveness 1  2  3  4  5 4.31

N/A, not available.

Table 2.

Characteristics of the 7 patients who were reconstructed

Age (year) BMI (kg/m2) Pathologic stage Tumor location Breast size Tumor weight (g) Previous implant size Changed implant size Oncologic surgery Postoperative chemotherapy Postoperative radiotherapy Surgical plane Use of ADM Postoperative complication
35 20.2 T1N0M0 UIQ 310/320 128 240 272 R/T Rt. NSM - - Subpectoral plane None None
47 17.7 T2N2M0 UMQ 300/305 119 210 253 R/T Rt. SSM Done - Subpectoral plane None Capsular contracture
31 18.1 T1N1M0 UMQ 290/290 146 203 250 R/T Rt. NSM Done - Subglandular plane ADM (sling) None
46 21.9 T1N0M0 UIQ 330/340 134 210 272 R/T Lt. SSM - - Subpectoral plane None None
54 20.6 T1N1M0 UOQ 380/370 260 203 401 R/T Lt. NSM Done - Subglandular plane ADM (sling) Seroma
38 17.5 T1N1M0 UOQ 320/310 142 253 322 R/T Lt. SSM Done - Subpectoral plane ADM (onlay) None
53 19.5 T1N0M0 UOQ 390/380 121 272 368 R/T Lt. NSM Done - Subglandular plane ADM (sling) None

BMI, body mass index; ADM, acellular dermal matrix; UIQ, upper inner quadrant; UMQ, upper medial quadrant; UOQ, upper outer quadrant; R, round; T, textured; Rt., right; Lt., left; NSM, nipple-sparing mastectomy; SSM, skin-sparing mastectomy.